PDT Partners’s Immunomedics Inc IMMU Stock Holding History

PDT Partners’s Portfolio IMMU Stock Details IMMU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-263,490	Closed	-$5.58M	–	919
2019 Q4	$5.58M	Buy	+263,490	New	+$4.65M	0.34%	105

Other funds holding IMMU

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

PDT Partners's IMMU Position: Q1 2020 in Review

PDT Partners sold out of Immunomedics Inc (IMMU) in Q1 2020, closing a stake of 263,490 shares — an estimated $5.58M sold.

PDT Partners first reported a position in IMMU in Q4 2019 and held it in 1 quarter. The position peaked at $5.58M in Q4 2019. 220 funds tracked by Wall St. Rank hold IMMU as of Q1 2020.

PDT Partners reported no remaining Immunomedics Inc position as of Q1 2020 after selling out during the quarter.
PDT Partners sold 263,490 Immunomedics Inc shares in Q1 2020, an estimated $5.58M.
PDT Partners first reported a position in Immunomedics Inc in Q4 2019 and held it in 1 quarter.
PDT Partners's Immunomedics Inc position peaked at $5.58M in Q4 2019.
220 funds tracked by Wall St. Rank held Immunomedics Inc as of Q1 2020.

Based on PDT Partners's 13F filing for Q1 2020, filed 15 May 2020.